地诺单抗：骨巨细胞瘤治疗的突破？ - Suppr

Suppr

超能文献

Denosumab: a breakthrough in treatment of giant-cell tumour of bone?

作者信息

Balke Maurice, Hardes Jendrik

出版信息

Lancet Oncol. 2010 Mar;11(3):218-9. doi: 10.1016/S1470-2045(10)70027-9. Epub 2010 Feb 10.

DOI:10.1016/S1470-2045(10)70027-9

PMID:20149737

Abstract

摘要

相似文献

Denosumab: a breakthrough in treatment of giant-cell tumour of bone?

Lancet Oncol. 2010 Mar;11(3):218-9. doi: 10.1016/S1470-2045(10)70027-9. Epub 2010 Feb 10.

Safety and efficacy of denosumab in giant-cell tumour of bone.

Lancet Oncol. 2010 Jun;11(6):513-4. doi: 10.1016/S1470-2045(10)70059-0.

RANKL, denosumab, and giant cell tumor of bone.

Curr Opin Oncol. 2012 Jul;24(4):397-403. doi: 10.1097/CCO.0b013e328354c129.

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study.

Lancet Oncol. 2010 Mar;11(3):275-80. doi: 10.1016/S1470-2045(10)70010-3. Epub 2010 Feb 10.

Safety of denosumab in giant-cell tumour of bone.

Lancet Oncol. 2010 Sep;11(9):815. doi: 10.1016/S1470-2045(10)70170-4.

Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.

Clin Cancer Res. 2012 Aug 15;18(16):4415-24. doi: 10.1158/1078-0432.CCR-12-0578. Epub 2012 Jun 18.

Denosumab: Excellent response of metastatic giant cell tumor of the bone.

J BUON. 2015 Mar-Apr;20(2):666-7.

Critical hypercalcemia following discontinuation of denosumab therapy for metastatic giant cell tumor of bone.

Pediatr Blood Cancer. 2015 Jun;62(6):1078-80. doi: 10.1002/pbc.25393. Epub 2015 Jan 3.

Denosumab: a new treatment option for giant cell tumor of bone.

Drugs Today (Barc). 2013 Nov;49(11):693-700. doi: 10.1358/dot.2013.49.11.2064725.

Giant cell tumour of bone.

Curr Opin Oncol. 2009 Jul;21(4):338-44. doi: 10.1097/CCO.0b013e32832c951d.

引用本文的文献

Giant cell tumor of soft tissue involving thyroid gland: a case report and review of the literature.

J Med Case Rep. 2024 Mar 22;18(1):123. doi: 10.1186/s13256-024-04450-1.

Management of Giant Cell Tumor of the Hyoid bone- A rare Clinical Entity with Review of Literature.

Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):4232-4235. doi: 10.1007/s12070-023-04094-5. Epub 2023 Jul 22.

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial.

J Bone Oncol. 2022 Jun 24;35:100441. doi: 10.1016/j.jbo.2022.100441. eCollection 2022 Aug.

Role of Zoledronic Acid Supplementation in Reducing Post-Surgical Recurrence of Giant Cell Tumor of Bone: A Meta-Analysis of Comparative Studies.

Cureus. 2021 Jul 29;13(7):e16742. doi: 10.7759/cureus.16742. eCollection 2021 Jul.

Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?

Clin Orthop Relat Res. 2018 Sep;476(9):1783-1790. doi: 10.1007/s11999.0000000000000104.

Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial.

J Bone Oncol. 2019 Jan 23;15:100217. doi: 10.1016/j.jbo.2019.100217. eCollection 2019 Apr.

Custom 3D-printed finger proximal phalanx as salvage of limb function after aggressive recurrence of giant cell tumour.

BMJ Case Rep. 2018 Sep 18;2018:bcr-2018-226007. doi: 10.1136/bcr-2018-226007.

A large giant cell tumor of the larynx: case report and review of the literature.

J Otolaryngol Head Neck Surg. 2017 Apr 4;46(1):26. doi: 10.1186/s40463-017-0198-y.

Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.

Pathol Oncol Res. 2017 Jan;23(1):157-164. doi: 10.1007/s12253-016-0123-0. Epub 2016 Oct 8.

Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.

PLoS One. 2016 Feb 10;11(2):e0148401. doi: 10.1371/journal.pone.0148401. eCollection 2016.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验